Article
Estrogen Receptor Alpha Mutations in Breast Cancer Cells Cause Gene Expression Changes through Constant Activity and Secondary Effects.
Cancer research - 1 Feb 2021
Arnesen Spencer, Blanchard Zannel, Williams Michelle M, Berrett Kristofer C, Li Zheqi, Oesterreich Steffi, Richer Jennifer K, Gertz Jason
Abstract excerpt
While breast cancer patients with tumors that express estrogen receptor α (ER) generally respond well to hormone therapies that block ER activity, a significant number of patients relapse. Approximately 30% of these recurrences harbor activating mutations in the ligand binding domain (LBD) of ER, which have been shown to confer ligand-independent function. However, much is still unclear regarding the effect of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
